专利检索 ap:("AMGEN INC.") AND inv:"Julie Anne Heath" 第 1 页

1.

发明申请
COMPOUNDS FOR USE IN PREPARING HETEROCYCLIC TRIAZOLE AGONISTS OF THE APJ RECEPTOR 审中-公开

公开(公告)号：US20180222895A1

公开(公告)日：2018-08-09

申请号：US15945852

申请日：2018-04-05

申请人： AMGEN INC.

发明人： Xiaoqi Chen , Alan C. Cheng , Richard V. Connors , Mikkel V. Debenedetto , Paul John Dransfield , Zice Fu , James S. Harvey , Julie Anne Heath , Jonathan Houze , Ted C. Judd , David John Kopecky , Su-Jen Lai , Zhihua Ma , Nobuko Nishimura , Steven H. Olson , Vatee Pattaropong , Xiaodong Wang

IPC分类号： C07D405/14 , C07D409/14 , C07D403/14 , C07D403/04 , C07D401/14 , A61K45/06 , A61K31/4439 , A61K31/437 , A61K31/506 , A61K31/5383 , C07D498/04 , C07D405/04 , C07D471/04 , A61K31/497

CPC分类号： C07D405/14 , A61K31/437 , A61K31/4439 , A61K31/497 , A61K31/506 , A61K31/5383 , A61K45/06 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/04 , C07D409/14 , C07D471/04 , C07D498/04

摘要： Compounds of Formula V, salts thereof, tautomers thereof, and salts of the tautomers have the following structure and are useful compounds in preparing small molecule agonists of the APJ Receptor: where the definitions of the variables are provided herein.

2.

发明申请
TRIAZOLE AGONISTS OF THE APJ RECEPTOR 有权
标题翻译： APJ受体的三唑激动剂

公开(公告)号：US20160340336A1

公开(公告)日：2016-11-24

申请号：US15158174

申请日：2016-05-18

申请人： AMGEN INC.

发明人： Ning Chen , Xiaoqi Chen , Yinhong Chen , Alan C. Cheng , Richard V. Connors , Jeffrey Deignan , Paul John Dransfield , Xiaohui Du , Zice Fu , Julie Anne Heath , Daniel B. Horne , Jonathan Houze , Matthew R. Kaller , Aarif Yusuf Khakoo , David John Kopecky , Su-Jen Lai , Zhihua Ma , Lawrence R. McGee , Julio C. Medina , Jeffrey T. Mihalic , Nobuko Nishimura , Steven H. Olson , Vatee Pattaropong , Gayathri Swaminath , Xiaodong Wang , Kevin Yang , Wen-Chen Yeh , Mikkel V. Debenedetto , Robert P. Farrell , Simon J. Hedley , Ted C. Judd , Frank Kayser

IPC分类号： C07D401/14 , C07D213/82 , C07D241/24 , C07D239/30 , C07D239/26 , C07D401/04 , A61K31/4439 , A61K31/506 , C07D413/14 , C07B59/00 , A61K31/497 , A61K31/513 , C07D471/04 , A61K31/444 , C07D417/14 , C07B57/00 , C07D405/14 , A61K31/501 , C07D249/08 , C07D241/12 , C07D213/71 , C07D211/54 , A61K45/06

CPC分类号： A61K31/506 , A61K31/437 , A61K31/4439 , A61K31/444 , A61K31/497 , A61K31/501 , A61K31/513 , A61K31/695 , A61K45/06 , C07B57/00 , C07B59/002 , C07B2200/05 , C07B2200/07 , C07C311/13 , C07D211/54 , C07D213/61 , C07D213/71 , C07D213/82 , C07D239/26 , C07D239/30 , C07D239/34 , C07D241/12 , C07D241/18 , C07D241/24 , C07D249/08 , C07D295/16 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/14 , C07D413/04 , C07D413/14 , C07D417/14 , C07D471/04 , C07F7/08

摘要： Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.

摘要翻译： 其中在这里提供变量的定义。

3.

发明申请
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER 审中-公开

公开(公告)号：US20140011796A1

公开(公告)日：2014-01-09

申请号：US14025688

申请日：2013-09-12

申请人： AMGEN INC.

发明人： Michael David BARTBERGER , Ana Gonzalez Buenrostro , Hilary Plake Beck , Xiaoqi Chen , Richard Victor Connors , Jeffrey Deignan , Jason Duquette , John Eksterwicz , Benjamin Fisher , Brian Matthew Fox , Jiasheng Fu , Zice Fu , Felix Gonzalez Lopez De Turiso , Michael William Gribble , Dann James Gustin , Julie Anne Heath , Xin Huang , Xianyun Jiao , Michael Johnson , Frank Kayser , David John Kopecky , Sujen Lai , Yihong Li , Zhihong Li , Jiwen Liu , Jonathan Dante Low , Brian Stuart Lucas , Zhihua Ma , Lawrence R. McGee , Joel McIntosh , Dustin McMinn , Julio Cesar Medina , Jeffrey Thomas Mihalic , Steven Howard Olson , Yosup Rew , Philip Marley Roveto , Daqing Sun , Xiaodong Wang , Yingcai Wang , Xuelei Yan , Ming Yu , Jiang Zhu

IPC分类号： C07D211/76 , C07D417/12 , C07D413/06 , C07D471/10 , C07D409/04 , C07D401/04 , C07D279/02 , C07D491/08 , C07D498/08 , C07D417/14 , C07D491/153 , C07D417/06 , C07D401/06 , C07D405/04

CPC分类号： C07D211/76 , C07D221/20 , C07D279/02 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/12 , C07D407/04 , C07D407/06 , C07D409/04 , C07D409/12 , C07D413/06 , C07D417/06 , C07D417/12 , C07D417/14 , C07D471/10 , C07D491/08 , C07D491/153 , C07D498/08 , C07D498/14 , C07D498/20

摘要： The present invention provides MDM2 inhibitor compounds of Formula I, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.

4.

发明授权
Cycloalkyl substituted triazole compounds as agonists of the APJ receptor 有权

公开(公告)号：US11020395B2

公开(公告)日：2021-06-01

申请号：US16347942

申请日：2017-11-03

申请人： AMGEN INC.

发明人： Yinhong Chen , Paul John Dransfield , James S. Harvey , Julie Anne Heath , Jonathan Houze , Aarif Yusuf Khakoo , David J. Kopecky , Su-Jen Lai , Zhihua Ma , Nobuko Nishimura , Vatee Pattaropong , Gayathri Swaminath , Wen-Chen Yeh , Philip Dean Ramsden

IPC分类号： A61K31/506 , A61P9/04 , C07D403/12 , C07D405/14 , C07D401/14 , C07D413/04 , C07D403/14 , A61K31/4439 , C07D401/04 , A61K31/4196 , C07D249/14

摘要： Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: (I) (II) where the definitions of the variables are provided herein.

5.

发明授权
Bromotriazole intermediates 有权

公开(公告)号：US10344016B2

公开(公告)日：2019-07-09

申请号：US16207360

申请日：2018-12-03

申请人： AMGEN INC.

发明人： Paul John Dransfield , Zice Fu , Julie Anne Heath , Jeffrey T. Mihalic , Vatee Pattaropong

IPC分类号： C07D401/04 , C07D401/14 , C07D401/12 , C07D405/14 , C07D417/14 , A61K45/06 , C07B57/00 , C07B59/00 , C07D211/54 , C07D213/71 , C07D213/82 , C07D239/26 , C07D239/30 , C07D241/12 , C07D241/24 , C07D249/08 , C07D471/04 , C07D413/14 , C07D413/04 , C07D213/61 , C07D239/34 , C07D241/18 , C07F7/08 , C07D295/16 , C07C311/13 , A61K31/695 , A61K31/4439 , A61K31/444 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/513 , A61K31/437

摘要： Bromotriazole intermediates are useful in the synthesis of agonists of the APH receptor. Such compounds include those selected from

6.

发明授权
Methods of treating heart failure 有权

公开(公告)号：US10058550B2

公开(公告)日：2018-08-28

申请号：US15629567

申请日：2017-06-21

申请人： AMGEN INC.

发明人： Ning Chen , Xiaoqi Chen , Yinhong Chen , Zice Fu , Julie Anne Heath , Daniel B. Horne , Matthew R. Kaller , Aarif Yusuf Khakoo , David John Kopecky , Zhihua Ma , Jeffrey T. Mihalic , Gayathri Swaminath , Xiaodong Wang , Wen-Chen Yeh

IPC分类号： A61K31/506 , A61K31/497 , A61K45/06

CPC分类号： C07D401/14 , A61K31/437 , A61K31/4439 , A61K31/444 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/513 , A61K31/695 , A61K45/06 , C07B57/00 , C07B59/002 , C07B2200/05 , C07B2200/07 , C07C311/13 , C07D211/54 , C07D213/61 , C07D213/71 , C07D213/82 , C07D239/26 , C07D239/30 , C07D239/34 , C07D241/12 , C07D241/18 , C07D241/24 , C07D249/08 , C07D295/16 , C07D401/04 , C07D401/12 , C07D405/14 , C07D413/04 , C07D413/14 , C07D417/14 , C07D471/04 , C07F7/08

摘要： Methods of treating heart failure include administering to a subject having heart failure an effective amount of a triazole compound that is an agonist of the APJ receptor, a pharmaceutically acceptable salt of the compound, or a mixture thereof. Compounds particularly useful in such methods are provided herein.

7.

发明授权
Methods for preparing triazole agonists of the APJ receptor 有权

公开(公告)号：US09751864B2

公开(公告)日：2017-09-05

申请号：US15298434

申请日：2016-10-20

申请人： AMGEN INC.

发明人： Ning Chen , Xiaoqi Chen , Richard V. Connors , Jeffrey Deignan , Paul John Dransfield , Xiaohui Du , Zice Fu , Julie Anne Heath , Daniel B. Horne , Jonathan Houze , Matthew R. Kaller , David John Kopecky , Su-Jen Lai , Zhihua Ma , Lawrence R. McGee , Julio C. Medina , Jeffrey T. Mihalic , Nobuko Nishimura , Steven H. Olson , Vatee Pattaropong , Xiaodong Wang , Kevin Yang , Mikkel V. DeBenedetto , Robert P. Farrell , Simon J. Hedley , Ted C. Judd

IPC分类号： C07D401/04 , C07D401/14 , C07D417/14 , C07D471/04 , C07D413/14 , C07D413/04 , A61K31/4439 , A61K31/444 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/513 , A61K45/06 , C07B57/00 , C07B59/00 , C07D211/54 , C07D213/71 , C07D213/82 , C07D239/26 , C07D239/30 , C07D241/12 , C07D241/24 , C07D249/08 , C07D405/14 , C07D401/12 , A61K31/695 , C07F7/08 , A61K31/437 , C07C311/13 , C07D213/61 , C07D239/34 , C07D241/18 , C07D295/16

CPC分类号： A61K31/506 , A61K31/437 , A61K31/4439 , A61K31/444 , A61K31/497 , A61K31/501 , A61K31/513 , A61K31/695 , A61K45/06 , C07B57/00 , C07B59/002 , C07B2200/05 , C07B2200/07 , C07C311/13 , C07D211/54 , C07D213/61 , C07D213/71 , C07D213/82 , C07D239/26 , C07D239/30 , C07D239/34 , C07D241/12 , C07D241/18 , C07D241/24 , C07D249/08 , C07D295/16 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/14 , C07D413/04 , C07D413/14 , C07D417/14 , C07D471/04 , C07F7/08

摘要： Methods of preparing compounds of Formula VI, salts thereof, tautomers thereof, or salts of the tautomers include cyclizing compounds of Formula V, salts thereof, tautomers thereof, or salts of the tautomers. Compounds of Formula VI and Formula V have the following structures: where the definitions of the variables are provided herein.

8.

发明授权
Triazole phenyl compounds as agonists of the APJ receptor 有权

公开(公告)号：US10906890B2

公开(公告)日：2021-02-02

申请号：US16347955

申请日：2017-11-03

申请人： AMGEN INC.

发明人： Ning Chen , Yinhong Chen , Mikkel V. Debenedetto , Paul John Dransfield , James S. Harvey , Julie Anne Heath , Jonathan Houze , Aarif Yusuf Khakoo , Su-Jen Lai , Zhihua Ma , Nobuko Nishimura , Vatee Pattaropong , Gayathri Swaminath , Wen-Chen Yeh , Charles Kreiman

IPC分类号： C07D403/14 , C07D239/24 , C07D241/12 , C07D249/14 , C07D401/04 , C07D403/04 , C07D403/12 , C07D405/14 , C07D417/12 , C07D417/14 , C07D239/26 , A61P9/04 , C07D401/14

摘要： Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: (I), (II) where the definitions of the variables are provided herein.